Published: Jun 18, 2021
RESEARCH TRIANGLE PARK, N.C., June 18, 2021 (GLOBE NEWSWIRE) G1 Therapeutics Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the appointment of Alicia Secor to its Board of Directors. With more than 30 years of experience in the life sciences industry, she has a proven track record of leading life sciences businesses, guiding products from clinical development through approval and global commercialization, and enabling companies to optimize the potential of innovative brands. Ms. Secor currently serves as President and Chief Executive Officer of Atalanta Therapeutics, Inc., a privately held biotechnology company pioneering new treatment options for neurodegenerative diseases and is a member of its Board of Directors.
Search jobs 17-Jul-2021 Global Premature Labor Treatment Market Comprehensive Research Study, Industry Size, Production Development and Opportunities 2021 to 2026
MarketQuest.biz include historical and projected data for the industry, as well as statistics on global socio-economic data. The scope of this market research report includes industry research, customer insights, market sizing & forecast, competitive analysis, market entry strategy, pricing trends, sustainability trends, and innovation trends. This research report can be used by both established and new players in the industry for a complete understanding of the global Premature Labor Treatment market.
The report provides an in-depth analysis of the market’s drivers and restraints. It sheds light on strategic production, revenue, and consumption trends for players to improve sales and growth in the market. Players can use the accurate market facts and figures and statisti
G1 Therapeutics Announces Addition of Alicia Secor to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.